Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location.

@article{Hill2014OvarianRA,
  title={Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location.},
  author={Micah J. Hill and Janelle C Cooper and G. Levy and Connie E Alford and Kevin Richter and Alan H. Decherney and Charles L Katz and Eric D. Levens and Erin Foran Wolff},
  journal={Fertility and sterility},
  year={2014},
  volume={101 2},
  pages={413-9}
}
OBJECTIVE To assess ovarian reserve after methotrexate treatment for ectopic pregnancy or pregnancy of unknown location after assisted reproductive technology (ART). DESIGN Retrospective cohort study. SETTING Large ART practice. PATIENT(S) Women receiving methotrexate or surgery after ART. INTERVENTION(S) None. MAIN OUTCOME MEASURE(S) Follicle-stimulating hormone (FSH), antral follicle count (AFC), and oocyte yield compared between women treated with methotrexate or surgery, with… CONTINUE READING
6 Extracted Citations
23 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 23 references

The role of anti-m€ ullerian hormone in female fertility and infertility—an overview

  • AG Grynnerup, A Lindhard, S. Sorensen
  • Acta Obstet Gynecol Scand 2012;91:1252–60
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…